General
impact 16
Long-lived immune cells show promise against cancer in world-first trial
Long-lived immune cells show promise against cancer in world-first trial Nature, Published online: 30 April 2026; doi:10.1038/d41586-026-01398-8 Blood cancer goes into remission for some people treated with a type of T…
Why it matters
The timing matters: cancer is converging with shifts in longlived, which could amplify the downstream impact.